Hepatic Encephalopathy

New England Journal of Medicine

Volumn 375, Issue 17, 2016, Pages 1660-1670

  Wijdicks, Eelco F M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMMONIA; BENZODIAZEPINE RECEPTOR; FLUMAZENIL; LACTULOSE; ORNITHINE ASPARTATE; PROBIOTIC AGENT; RIFAXIMIN;

ACUTE LIVER FAILURE; ACUTE ON CHRONIC LIVER FAILURE; ALBUMIN DIALYSIS; ALCOHOLIC DELIRIUM; BRAIN EDEMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; END STAGE LIVER DISEASE; EPILEPTIC STATE; FULMINANT HEPATIC FAILURE; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; INTENSIVE CARE; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HYPERTENSION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MODEL FOR END STAGE LIVER DISEASE SCORE; NERVOUS SYSTEM INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SUBDURAL HEMATOMA; WERNICKE KORSAKOFF SYNDROME; CLASSIFICATION; COMPLICATION; PATHOLOGY; PATHOPHYSIOLOGY;

BRAIN EDEMA; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA; LACTULOSE;

EID: 84992709503     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1600561     Document Type: Review

References (82)

1. Fichet J, Mercier E, Genée O, et al. Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy. J Crit Care 2009; 24: 364-70.
2. García-Martínez R, Simón-Talero M, Córdoba J. Prognostic assessment in patients with hepatic encephalopathy. Dis Markers 2011; 31: 171-9.
3. Wong RJ, Gish RG, Ahmed A. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation. Liver Transpl 2014; 20: 1454-61.
4. Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol 2013; 59: 74-80.
5. Reuben A, Tillman H, Fontana RJ, et al. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study. Ann Intern Med 2016; 164: 724-32.
6. Adams RD, Foley JM. The neurologic changes in the more common types of severe liver disease. Trans Am Neurol Assoc 1949; 74: 217-9.
7. Butterworth RF. Hepatic encephalopathy in alcoholic cirrhosis. Handb Clin Neurol 2014; 125: 589-602.
8. Butterworth RF. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure. J Clin Exp Hepatol 2015; 5: Suppl 1: S96-103.
9. Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013; 369: 2525-34.
10. Butterworth RF, Giguére JF, Michaud J, Lavoie J, Layrargues GP. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987; 6: 1-12.
11. Barbaro G, Di Lorenzo G, Soldini M, et al. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter doubleblind, placebo-controlled, cross-over study. Hepatology 1998; 28: 374-8.
12. Butterworth RF, Pomier Layrargues G. Benzodiazepine receptors and hepatic encephalopathy. Hepatology 1990; 11: 499-501.
13. Butterworth RF. Neurosteroids in hepatic encephalopathy: novel insights and new therapeutic opportunities. J Steroid Biochem Mol Biol 2016; 160: 94-7.
14. Butterworth RF, Spahr L, Fontaine S, Layrargues GP. Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab Brain Dis 1995; 10: 259-67.
15. Odeh M. Pathogenesis of hepatic encephalopathy: the tumour necrosis factoralpha theory. Eur J Clin Invest 2007; 37: 291-304.
16. Ong JP, Aggarwal A, Krieger D, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 2003; 114: 188-93.
17. Ge PS, Runyon BA. Serum ammonia level for the evaluation of hepatic encephalopathy. JAMA 2014; 312: 643-4.
18. Riggio O, Angeloni S, Salvatori FM, et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol 2008; 103: 2738-46.
19. Rössle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-71.
20. Saad WE. Portosystemic shunt syndrome and endovascular management of hepatic encephalopathy. Semin Intervent Radiol 2014; 31: 262-5.
21. Nardelli S, Gioia S, Pasquale C, et al. Cognitive impairment predicts the occurrence of hepatic encephalopathy after trans jugular intrahepatic portosystemic shunt. Am J Gastroenterol 2016; 111: 523-8.
22. Bessman SP, Fazekas JF, Bessman AN. Uptake of ammonia by the brain in hepatic coma. Proc Soc Exp Biol Med 1954; 85: 66-7.
23. Fazekas JF, Ticktin HE, Shea JG. Effect of 1-glutamic acid on metabolism of patients with hepatic encephalopathy. Am J Med Sci 1957; 234: 145-9.
24. Foley JM, Watson CW, Adams RD. Significance of the electroencephalographic changes in hepatic coma. Trans Am Neurol Assoc 1950; 51: 161-5.
25. Murphy TL, Chalmers TC, Eckhardt RD, Davidson CS. Hepatic coma: clinical and laboratory observations on 40 patients. N Engl J Med 1948; 239: 605-12.
26. Phillips GB, Schwartz R, Gabuzda GJ Jr., Davidson CS. The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances. N Engl J Med 1952; 247: 239-46.
27. Snell AM, Butt HR. Hepatic coma; observations bearing on its nature and treatment. Tr A Am Physicians 1941; 56: 321-9.
28. Sherlock S, Summerskill WH, White LP, Phear EA. Portal-systemic encephalopathy: neurological complications of liver disease. Lancet 1954; 267: 454-7.
29. Frerichs FT. A clinical treatise on diseases of the liver. London: The New Sydenham Society, 1860.
30. Bajaj JS, Cordoba J, Mullen KD, et al. Review article: the design of clinical trials in hepatic encephalopathy-An International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 2011; 33: 739-47.
31. Wijdicks EF, Rabinstein AA, Bamlet WR, Mandrekar JN. FOUR score and Glasgow Coma Scale in predicting outcome of comatose patients: a pooled analysis. Neurology 2011; 77: 84-5.
32. Bajaj JS. Current and future diagnosis of hepatic encephalopathy. Metab Brain Dis 2010; 25: 107-10.
33. Kappus MR, Bajaj JS. Covert hepatic encephalopathy: not as minimal as you might think. Clin Gastroenterol Hepatol 2012; 10: 1208-19.
34. Vanamee P, Poppell JW, Glicksman AS, Randall HT, Roberts KE. Respiratory alkalosis in hepatic coma. AMA Arch Intern Med 1956; 97: 762-7.
35. Mouri S, Tripon S, Rudler M, et al. FOUR score, a reliable score for assessing overt hepatic encephalopathy in cirrhotic patients. Neurocrit Care 2015; 22: 251-7.
36. Bandmann O, Weiss KH, Kaler SG. Wilson's disease and other neurological copper disorders. Lancet Neurol 2015; 14: 103-13.
37. Bickford RG, Butt HR. Hepatic coma: the electroencephalographic pattern. J Clin Invest 1955; 34: 790-9.
38. Silverman D. Some observations on the EEG in hepatic coma. Electroencephalogr Clin Neurophysiol 1962; 14: 53-9.
39. Marchetti P, D'Avanzo C, Orsato R, et al. Electroencephalography in patients with cirrhosis. Gastroenterology 2011; 141(5): 1680-9.e1-2.
40. Sutter R, Kaplan PW. Uncovering clinical and radiological associations of triphasic waves in acute encephalopathy: a case-control study. Eur J Neurol 2014; 21: 660-6.
41. Ficker DM, Westmoreland BF, Sharbrough FW. Epileptiform abnormalities in hepatic encephalopathy. J Clin Neurophysiol 1997; 14: 230-4.
42. Olesen SS, Gram M, Jackson CD, et al. Electroencephalogram variability in patients with cirrhosis associates with the presence and severity of hepatic encephalopathy. J Hepatol 2016; 65: 517-23.
43. Sawhney IM, Verma PK, Dhiman RK, et al. Visual and auditory evoked responses in acute severe hepatitis. J Gastroenterol Hepatol 1997; 12: 554-9.
44. Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-23.
45. Amodio P, Montagnese S. Clinical neurophysiology of hepatic encephalopathy. J Clin Exp Hepatol 2015; 5: Suppl 1: S60-8.
46. Schiff S, Casa M, Di Caro V, et al. A low-cost, user-friendly electroencephalographic recording system for the assessment of hepatic encephalopathy. Hepatology 2016; 63: 1651-9.
47. Guerit JM, Amantini A, Fischer C, et al. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009; 29: 789-96.
48. Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome. Philadelphia: F.A. Davis, 1989.
49. Davidson EA, Solomon P. The differentiation of delirium tremens from impending hepatic coma. J Ment Sci 1958; 104: 326-33.
50. Guevara M, Baccaro ME, Torre A, et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol 2009; 104: 1382-9.
51. Jhun P, Kim H. Nonconvulsive status epilepticus in hepatic encephalopathy. West J Emerg Med 2011; 12: 372-4.
52. Schmidt L, Gørtz S, Wohlfahrt J, Melbye M, Munch TN. Recurrence of subdural haematoma in a population-based cohort-risks and predictive factors. PLoS One 2015; 10(10): e0140450.
53. Donovan LM, Kress WL, Strnad LC, et al. Low likelihood of intracranial hemorrhage in patients with cirrhosis and altered mental status. Clin Gastroenterol Hepatol 2015; 13: 165-9.
54. Nielsen K, Clemmesen JO, Vassiliadis E, Vainer B. Liver collagen in cirrhosis correlates with portal hypertension and liver dysfunction. APMIS 2014; 122: 1213-22.
55. American Association for the Study of Liver Diseases, European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol 2014; 61: 642-59.
56. Cabral CM, Burns DL. Low-protein diets for hepatic encephalopathy debunked: let them eat steak. Nutr Clin Pract 2011; 26: 155-9.
57. Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010; 362: 1071-81.
58. McGee RG, Bakens A, Wiley K, Riordan SM, Webster AC. Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev 2011; 11: CD008716.
59. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
60. Martin P, DiMartini A, Feng S, Brown R Jr., Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 2014; 59: 1144-65.
61. Lee WM. Acute liver failure. Semin Respir Crit Care Med 2012; 33: 36-45.
62. Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000; 28: 3301-13.
63. Rabinstein AA. Treatment of brain edema in acute liver failure. Curr Treat Options Neurol 2010; 12: 129-41.
64. Tyagi R, Donaldson K, Loftus CM, Jallo J. Hypertonic saline: a clinical review. Neurosurg Rev 2007; 30: 277-90.
65. Wijdicks EF, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 2002; 34: 1220-2.
66. Kitzberger R, Funk GC, Holzinger U, et al. Severity of organ failure is an independent predictor of intracranial hypertension in acute liver failure. Clin Gastroenterol Hepatol 2009; 7: 1000-6.
67. Karvellas CJ, Todd Stravitz R, Battenhouse H, Lee WM, Schilsky ML. Therapeutic hypothermia in acute liver failure: a multicenter retrospective cohort analysis. Liver Transpl 2015; 21: 4-12.
68. Thayapararajah SW, Gulka I, Al-Amri A, Das S, Young GB. Acute fulminant hepatic failure, encephalopathy and early CT changes. Can J Neurol Sci 2013; 40: 553-7.
69. Vaquero J, Fontana RJ, Larson AM, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 2005; 11: 1581-9.
70. Karvellas CJ, Fix OK, Battenhouse H, Durkalski V, Sanders C, Lee WM. Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study. Crit Care Med 2014; 42: 1157-67.
71. Maloney PR, Mallory GW, Atkinson JL, Wijdicks EF, Rabinstein AA, Van Gompel JJ. Intracranial pressure monitoring in acute liver failure: institutional case series. Neurocrit Care 2016; 25: 86-93.
72. Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004; 39: 464-70.
73. Bernal W, Murphy N, Brown S, et al. A multicentre randomized controlled trial of moderate hypothermia to prevent intracranial hypertension in acute liver failure. J Hepatol 2016; 65: 273-9.
74. Olin P, Hausken J, Foss A, Karlsen TH, Melum E, Haugaa H. Continuous molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation. Scand J Gastroenterol 2015; 50: 1127-34.
75. Stutchfield BM, Simpson K, Wigmore SJ. Systematic review and meta-Analysis of survival following extracorporeal liver support. Br J Surg 2011; 98: 623-31.
76. Jalan R, Olde Damink SW, Hayes PC, Deutz NE, Lee A. Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol 2004; 41: 613-20.
77. Aggarwal S, Obrist W, Yonas H, et al. Cerebral hemodynamic and metabolic profiles in fulminant hepatic failure: relationship to outcome. Liver Transpl 2005; 11: 1353-60.
78. Häussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2006; 43: 1187-90.
79. Keiding S, Pavese N. Brain metabolism in patients with hepatic encephalopathy studied by PET and MR. Arch Biochem Biophys 2013; 536: 131-42.
80. Lodi R, Tonon C, Stracciari A, et al. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology 2004; 62: 762-6.
81. Donovan JP, Schafer DF, Shaw BW Jr., Sorrell MF. Cerebral oedema and increased intracranial pressure in chronic liver disease. Lancet 1998; 351: 719-21.
82. Cauli O, Llansola M, Agustí A, et al. Cerebral oedema is not responsible for motor or cognitive deficits in rats with hepatic encephalopathy. Liver Int 2014; 34: 379-87.